Inflammatory breast cancer and development of brain metastases: risk factors and outcomes. (Q48220470)

http://europepmc.org/abstract/MED/25893587

9 February 2018

title

Inflammatory breast cancer and development of brain metastases: risk factors and outcomes. (English)

1 reference

http://europepmc.org/abstract/MED/25893587

9 February 2018

1 reference

inflammatory breast cancer

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893587%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Hao Guo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893587%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Meredith M Regan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893587%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Faina Nakhlis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893587%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Eren D Yeh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893587%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Heather A Jacene

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893587%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Judi Hirshfield-Bartek

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893587%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Beth A Overmoyer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893587%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jennifer R Bellon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893587%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

17 April 2015

1 reference

http://europepmc.org/abstract/MED/25893587

9 February 2018

published in

Breast Cancer Research and Treatment

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893587%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893587%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

225-232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893587%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25893587%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-015-3381-8

9 June 2020

exact match

0 references

cites work

Breast carcinoma: Pattern of metastasis at autopsy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Central nervous system metastasis from breast carcinoma. Autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Metastatic behavior of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Brain metastases in breast cancer; natural history, prognostic factors and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Metastasis: from dissemination to organ-specific colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Validation of the graded prognostic assessment index for patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

A randomized trial of surgery in the treatment of single metastases to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

The management of metastases to the brain by irradiation and corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Brain metastases in breast cancer: prognostic factors and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Incidence of and survival following brain metastases among women with inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

The natural history of breast cancer patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8

Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3381-8